# Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients

> **NCT03182699** · PHASE4 · COMPLETED · sponsor: **Rainer Oberbauer** · enrollment: 62 (actual)

## Conditions studied

- Secondary Hyperparathyroidism
- Chronic Kidney Disease Requiring Chronic Dialysis
- Left Ventricular Hypertrophy

## Interventions

- **DIAGNOSTIC_TEST:** cardiac MRI
- **DIAGNOSTIC_TEST:** echocardiography with strain
- **DIAGNOSTIC_TEST:** Laboratory tests
- **DIAGNOSTIC_TEST:** Body composition monitoring
- **DIAGNOSTIC_TEST:** lung ultrasound

## Key facts

- **NCT ID:** NCT03182699
- **Lead sponsor:** Rainer Oberbauer
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-01
- **Primary completion:** 2019-12-20
- **Final completion:** 2019-12-20
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2020-06-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03182699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03182699, "Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03182699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*